Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Boehringer Ingelheim
Boehringer Ingelheim
Novartis
Janssen Research & Development, LLC
7 Hills Pharma, LLC
Bristol-Myers Squibb
Parabilis Medicines, Inc.
Genmab
Verastem, Inc.
Novartis
Revolution Medicines, Inc.
Ipsen
Recurv Pharma Inc
Revolution Medicines, Inc.
858 Therapeutics, Inc.
Radiopharm Theranostics, Ltd
Blue Earth Diagnostics
Erasca, Inc.
Eisai Inc.
GlaxoSmithKline
Alentis Therapeutics AG
Artios Pharma Ltd
Novartis
Frontier Medicines Corporation
Elicio Therapeutics
BioNTech SE
PMV Pharmaceuticals, Inc
Betta Pharmaceuticals Co., Ltd.
BioNTech SE
Akeso
Neonc Technologies, Inc.
A2 Biotherapeutics Inc.
AstraZeneca
Merus B.V.
Arvinas Inc.
Tasca Therapeutics
MBrace Therapeutics
Betta Pharmaceuticals Co., Ltd.
Revolution Medicines, Inc.
Luye Pharma Group Ltd.
GlaxoSmithKline
Syndax Pharmaceuticals
Chimeric Therapeutics
Auricula Biosciences Inc.
One-carbon Therapeutics AB
IDEAYA Biosciences
Bold Therapeutics, Inc.
Merck Sharp & Dohme LLC
Jacobio Pharmaceuticals Co., Ltd.
Lumicell, Inc.
Perspective Therapeutics